Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seales, E. C.
Right arrow Articles by Bellis, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seales, E. C.
Right arrow Articles by Bellis, S. L.
[Cancer Research 65, 4645-4652, June 1, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Hypersialylation of ß1 Integrins, Observed in Colon Adenocarcinoma, May Contribute to Cancer Progression by Up-regulating Cell Motility

Eric C. Seales1, Gustavo A. Jurado2, Brian A. Brunson2, John K. Wakefield3, Andra R. Frost1 and Susan L. Bellis2

Departments of 1 Pathology and 2 Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, Alabama and 3 Tranzyme, Inc., Research Triangle Park, North Carolina

Requests for reprints: Susan L. Bellis, Department of Physiology and Biophysics, Room 982A MCLM, 1918 University Boulevard, Birmingham, AL 35294. Phone: 205-934-3441; Fax: 205-975-9028; E-mail: bellis{at}physiology.uab.edu.

Colon adenocarcinomas are known to express elevated levels of {alpha}2-6 sialylation and increased activity of ST6Gal-I, the Golgi glycosyltransferase that creates {alpha}2-6 linkages. Elevated ST6Gal-I positively correlates with metastasis and poor survival, and therefore ST6Gal-I–mediated hypersialylation likely plays a role in colorectal tumor invasion. Previously we found that oncogenic ras (present in roughly 50% of colon adenocarcinomas) up-regulates ST6Gal-I and, in turn, increases sialylation of ß1 integrin adhesion receptors in colon epithelial cells. However, we wanted to know if this pattern held true in vivo and, if so, how ß1 hypersialylation might contribute to colon tumor progression. In the present study, we find that ß1 integrins from colon adenocarcinomas consistently carry higher levels of {alpha}2-6 sialic acid. To explore the effects of increased {alpha}2-6 sialylation on ß1-integrin function, we stably expressed ST6Gal-I in a colon epithelial cell line lacking endogenous ST6Gal-I. ST6Gal-I expressors (with {alpha}2-6 sialylated ß1 integrins) exhibited up-regulated attachment to collagen I and laminin and increased haptotactic migration toward collagen I, relative to parental cells (with completely unsialylated ß1 integrins). Blockade of ST6Gal-I expression with short interfering RNA reversed collagen binding back to the level of ST6Gal-I nonexpressors, confirming that {alpha}2-6 sialylation regulates ß1 integrin function. Finally, we show that ß1 integrins from ST6Gal-I expressors have increased association with talin, a marker for integrin activation. Collectively, these findings suggest that ß1 hypersialylation may augment colon tumor progression by altering cell preference for certain extracellular matrix milieus, as well as by stimulating cell migration.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Zhuo, R. Chammas, and S. L. Bellis
Sialylation of {beta}1 Integrins Blocks Cell Adhesion to Galectin-3 and Protects Cells against Galectin-3-induced Apoptosis
J. Biol. Chem., August 8, 2008; 283(32): 22177 - 22185.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
M. Lee, H.-J. Lee, S. Bae, and Y.-S. Lee
Protein Sialylation by Sialyltransferase Involves Radiation Resistance
Mol. Cancer Res., August 1, 2008; 6(8): 1316 - 1325.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Hedlund, E. Ng, A. Varki, and N. M. Varki
{alpha}2-6 Linked Sialic Acids on N-Glycans Modulate Carcinoma Differentiation In vivo
Cancer Res., January 15, 2008; 68(2): 388 - 394.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-B. Guo, M. Randolph, and M. Pierce
Inhibition of a Specific N-Glycosylation Activity Results in Attenuation of Breast Carcinoma Cell Invasiveness-related Phenotypes: INHIBITION OF EPIDERMAL GROWTH FACTOR-INDUCED DEPHOSPHORYLATION OF FOCAL ADHESION KINASE
J. Biol. Chem., July 27, 2007; 282(30): 22150 - 22162.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. Huang, J.-T. Liang, H.-C. Huang, T.-L. Shen, H.-Y. Chen, N.-Y. Lin, M.-I. Che, W.-C. Lin, and M.-C. Huang
{beta}1,4-N-Acetylgalactosaminyltransferase III Enhances Malignant Phenotypes of Colon Cancer Cells
Mol. Cancer Res., June 1, 2007; 5(6): 543 - 552.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
M. Chiricolo, N. Malagolini, S. Bonfiglioli, and F. Dall'Olio
Phenotypic changes induced by expression of {beta}-galactoside {alpha}2,6 sialyltransferase I in the human colon cancer cell line SW948
Glycobiology, February 1, 2006; 16(2): 146 - 154.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. C. Seales, F. M. Shaikh, A. V. Woodard-Grice, P. Aggarwal, A. C. McBrayer, K. M. Hennessy, and S. L. Bellis
A Protein Kinase C/Ras/ERK Signaling Pathway Activates Myeloid Fibronectin Receptors by Altering {beta}1 Integrin Sialylation
J. Biol. Chem., November 11, 2005; 280(45): 37610 - 37615.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.